Literature DB >> 3027905

A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension.

Y K Seedat, K B Parag.   

Abstract

The effects of lisinopril (MK-521; MSD) and atenolol in the treatment of mild-to-moderate essential hypertension were compared in a double-blind, parallel, controlled study, with 24 patients randomly assigned to lisinopril and 12 to atenolol. Patients in both groups whose blood pressure did not respond satisfactorily were given hydrochlorothiazide (HCTZ). The groups were matched for age, race and pretreatment blood pressure. Response to therapy was similar in the atenolol and lisinopril groups, but the combination of lisinopril and HCTZ produced a better response than atenolol plus HCTZ. Indian patients appeared to respond better to lisinopril than black patients, but the hypotensive response to lisinopril plus HCTZ was similar. Plasma renin activity rose and the plasma aldosterone level fell after taking lisinopril. Adverse effects did not occur and only 1 patient on lisinopril 20 mg/d was withdrawn from the study because of postural hypotension. Lisinopril alone and combined with HCTZ in Indian patients and lisinopril combined with HCTZ in black patients produced a satisfactory fall in blood pressure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027905

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.

Authors:  P J Anderson; J A Critchley; B Tomlinson; G Resplandy
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

2.  Racial differences in response to antihypertensive therapy: does one size fits all?

Authors:  Ajay K Gupta
Journal:  Int J Prev Med       Date:  2010

Review 3.  Perspectives on research in hypertension.

Authors:  Y K Seedat
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167

4.  Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis.

Authors:  Anna Seeley; Josephine Prynn; Rachel Perera; Rebecca Street; Daniel Davis; Anthony O Etyang
Journal:  BMC Med       Date:  2020-03-27       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.